OO
Omprakash Omkarmal Jain
About Omprakash Omkarmal Jain
Data last updated:
Omprakash Omkarmal Jain has 1 years in corporate governance. Holds Managing Director role. Currently with 1 company, including Sleepotex Overseas Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Sleepotex Overseas Private Limited at ₹24.06 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Sleepotex Overseas Private Limited U17299GJ2020PTC117677 | Managing Director | 18 Jun 2025 | 2020 | ₹24.06 Cr (FY 2025) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Omprakash Omkarmal Jain
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Omprakash Omkarmal Jain
Omprakash Omkarmal Jain has 1 years in corporate governance. Holds Managing Director role. Currently with 1 company, including Sleepotex Overseas Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Sleepotex Overseas Private Limited at ₹24.06 Cr (FY 2025).
Omprakash Omkarmal Jain is associated with 1 company as Managing Director, including Sleepotex Overseas Private Limited (₹24.06 Cr).
Omprakash Omkarmal Jain has expertise in General Business.
Omprakash Omkarmal Jain has 1 years in corporate governance.
By reported revenue, the largest current company of Omprakash Omkarmal Jain is Sleepotex Overseas Private Limited, with revenue of ₹24.06 Cr (FY 2025).
Omprakash Omkarmal Jain currently holds positions at 1 company: Sleepotex Overseas Private Limited (₹24.06 Cr).